申请人:Boehringer Ingelheim International GmbH
公开号:US20130030022A1
公开(公告)日:2013-01-31
Compounds of formula (I)
are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.